Needham Reiterates Buy on DocGo, Maintains $14 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.
August 08, 2023 | 10:10 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
DocGo's stock rating has been reiterated as 'Buy' by Needham analyst Ryan MacDonald, with a maintained price target of $14.
The reiteration of a 'Buy' rating by a reputable analyst like Ryan MacDonald from Needham is a positive signal for investors. The maintained price target of $14 indicates that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100